Publicaciones en las que colabora con Diego López Otero (10)

2022

  1. Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

    Medicina Clinica, Vol. 158, Núm. 7, pp. 315-323

  2. Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

2021

  1. Association between myocardial injury and prognosis of COVID-19 hospitalized patients, with or without heart disease. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 1, pp. 105-108

  2. Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 175-182

  3. Impact of significant paravalvular leaks after transcatheter aortic valve implantation on anaemia and mortality

    Heart, Vol. 107, Núm. 6, pp. 497-502

  4. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

    Cardiology journal, Vol. 28, Núm. 3, pp. 360-368

  5. Prognostic Impact of Change in Nutritional Risk on Mortality and Heart Failure After Transcatheter Aortic Valve Replacement

    Circulation. Cardiovascular interventions, Vol. 14, Núm. 2, pp. e009342

  6. The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Left ventricle myocardial deformation pattern in severe aortic valve stenosis without cardiac amyloidosis. The AMY-TAVI trial

    Revista Espanola de Cardiologia, Vol. 73, Núm. 11, pp. 961-964